GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » ROE %

Danimer Scientific (Danimer Scientific) ROE % : -54.18% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Danimer Scientific's annualized net income for the quarter that ended in Dec. 2023 was $-157.74 Mil. Danimer Scientific's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $291.15 Mil. Therefore, Danimer Scientific's annualized ROE % for the quarter that ended in Dec. 2023 was -54.18%.

The historical rank and industry rank for Danimer Scientific's ROE % or its related term are showing as below:

DNMR' s ROE % Range Over the Past 10 Years
Min: -117.72   Med: -40.95   Max: -4.75
Current: -47.23

During the past 5 years, Danimer Scientific's highest ROE % was -4.75%. The lowest was -117.72%. And the median was -40.95%.

DNMR's ROE % is ranked worse than
96.03% of 1538 companies
in the Chemicals industry
Industry Median: 5.21 vs DNMR: -47.23

Danimer Scientific ROE % Historical Data

The historical data trend for Danimer Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific ROE % Chart

Danimer Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
-117.72 -4.75 -14.04 -40.95 -47.43

Danimer Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.17 -39.98 -45.77 -50.63 -54.18

Competitive Comparison of Danimer Scientific's ROE %

For the Specialty Chemicals subindustry, Danimer Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danimer Scientific's ROE % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Danimer Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Danimer Scientific's ROE % falls into.



Danimer Scientific ROE % Calculation

Danimer Scientific's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-155.473/( (377.612+278.02)/ 2 )
=-155.473/327.816
=-47.43 %

Danimer Scientific's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-157.736/( (304.281+278.02)/ 2 )
=-157.736/291.1505
=-54.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Danimer Scientific  (NYSE:DNMR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-157.736/291.1505
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-157.736 / 43.78)*(43.78 / 709.5485)*(709.5485 / 291.1505)
=Net Margin %*Asset Turnover*Equity Multiplier
=-360.29 %*0.0617*2.4371
=ROA %*Equity Multiplier
=-22.23 %*2.4371
=-54.18 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-157.736/291.1505
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-157.736 / -157.728) * (-157.728 / -123.328) * (-123.328 / 43.78) * (43.78 / 709.5485) * (709.5485 / 291.1505)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0001 * 1.2789 * -281.7 % * 0.0617 * 2.4371
=-54.18 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Danimer Scientific ROE % Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Danimer Scientific (Danimer Scientific) Business Description

Traded in Other Exchanges
Address
140 Industrial Boulevard, Bainbridge, GA, USA, 39817
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Executives
Richard J Hendrix director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten officer: Chief Marketing Officer 286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt director 730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen director 1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian director
Michael A Hajost officer: Chief Financial Officer C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey director, officer: CEO & Chairman of the Board C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt director 303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D officer: Chief Technology Officer 1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun director 2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda director 1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith officer: Chief Operating Officer 2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco director 206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr 10 percent owner, officer: President, other: President CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367